Anja Mottok

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma”.

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

Haematologica(2021)10.3324/haematol.2020.271957

N/A

0.663DataRank · unranked

82 citations

Blanca González‐Farré, Alina Nicolae, Svetlana Pack, Guillem Clot, Ferran Nadeu +21 more

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0757-z

N/A

0.661DataRank · unranked

81 citations

Shannon Healy, Ali Bashashati, Saeed Saberi, Christoffer Hother, Anja Mottok +52 more

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Blood(2021)10.1182/blood.2021011941

N/A

0.639DataRank · unranked

17 citations

Anja Mottok, Fong Chun Chan, Aixiang Jiang, Arjan Diepstra, Lydia Visser +9 more

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0116

N/A

0DataRank · unranked

159 citations

Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain +24 more

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.22.445261

N/A

0DataRank · unranked

3 citations

Jie Gao, Shannon Healy, Christopher Rushton, Nicole Thomas, Laura K. Hilton +14 more